Insider Confidence Amid Decline: UTI Executives Buy Shares Below 52‑Week Low as Company Eyes Recovery
Insider Robert Thomas buys 1,000 UTI shares at $21.77—signaling confidence amid a steep 44% monthly decline and a potential recovery in tech training earnings.
3 minutes to read









